Full-Time

Medical Delivery Associate

Driver

Posted on 10/6/2025

Mallinckrodt

Mallinckrodt

1,001-5,000 employees

Specialty pharmaceutical developer, manufacturer, distributor

No salary listed

Dallas, TX, USA

In Person

Overnight travel required (2-4 nights per week).

Category
Operations & Logistics (3)
, ,
Required Skills
SAP Products
Customer Service
Oracle
Requirements
  • High School Diploma or equivalent with 1+ year of Commercial Driver’s License (CDL) experience.
  • Class A, B or C Commercial Driver’s License (CDL).
  • Must currently possess or willingness to successfully obtain a Hazmat endorsement within 30 days of hire.
  • History of compliance with DOT regulations
  • Must have proficient computer skills, ideally with experience using SAP, Oracle or equivalent ERP system, Warehouse Management System.
  • Overnight travel required (can be 2-4 nights/wk).
  • Required to pass a DOT physical and obtain a DOT certification.
  • Navigate and perform transactions in SAP accurately
  • Maintain a clean driver record
  • Detail oriented
  • Good written and oral communication skills
Responsibilities
  • Loads and secures products in the pre-assigned vehicle prior to departing for a scheduled or unscheduled route and properly unloads the assigned vehicle upon returning from a scheduled or unscheduled route. (Note - scheduled and unscheduled routes may regularly require overnight stays that are greater than one night).
  • Drives routes efficiently (i.e., follows the established route plan, reads maps, follows directions, and delivers/pick-ups product at the correct hospital campus/department), and immediately communicates any noteworthy exceptions to Customer Service and the Branch Manager.
  • Abides by all Department of Transportation (DOT) Regulations and ensures all required documentation is with the vehicle (proof of insurance, fuel card, vehicle registration, etc.).
  • Ensures proper delivery of product(s) on the customer order
  • Ensures that all driver logs and trip reports are completed timely and accurately.
  • Conveys a friendly, positive and professional image to both the internal (e.g., customer service department) and external customer (e.g., the account).
  • Responsible for warehousing, Inventory Control, Distribution and Administrative activities.
  • Creates appropriate paperwork for inbound/outbound transactions and retrieves route information from the network. etc.), as well as all company Standard Operation Procedures (SOPs).
  • Pick orders, handles returns from customers and enters INOmeter downloads.
  • Prepares 3rd party shipments, as well as contacts the appropriate carrier in a timely manner, and prepares the required paperwork to ensure compliance with all federal regulations.
  • Ensures that all warehouse and administrative functions are completed in accordance with company SOPs.
  • Interfacing directly with Mallinckrodt customers
  • Communicates with customer care and routing departments daily.
  • Schedule includes work between Monday and Friday.
  • Allowance given for food and lodging.
Desired Qualifications
  • Thorough knowledge of applicable Federal Regulations (cGMP, DOT, IATA, OSHA) strongly preferred

Mallinckrodt is a global specialty pharmaceutical company that develops, manufactures, and distributes drugs and therapies for complex and rare conditions, serving healthcare providers, hospitals, and patients mainly in the United States and Europe. Its products target areas such as autoimmune diseases, rare diseases, and critical care, and the business rests on research and development, manufacturing, and sales. The company differentiates itself through a patient-centric approach, a commitment to integrity, ongoing innovation, and collaboration, grounded in more than 150 years of experience and a focus on ESG initiatives. Its goal is to improve the health and well-being of patients worldwide by delivering specialty medicines and advancing sustainable practices.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Hazelwood, Missouri

Founded

1867

Simplify Jobs

Simplify's Take

What believers are saying

  • Merger with Endo completed, forming NYSE-listed therapeutics leader by Q4 2025.
  • Reduced debt 47% to $865.6M and grew Acthar Gel sales 14.2% in 2024.
  • Sold Therakos for $925M, optimizing portfolio for specialty pharmaceuticals.

What critics are saying

  • Endo merger integration disrupts operations, overloading with $6.7B debt.
  • Therakos sale drops immunotherapy revenue, losing edge to Amgen immediately.
  • Acthar Gel's $300K pricing triggers DOJ probe and $500M fines within 18 months.

What makes Mallinckrodt unique

  • Mallinckrodt specializes in Acthar Gel for autoimmune diseases over 150 years.
  • Focuses on rare diseases and critical care therapies for underserved patients.
  • Launched Acthar Gel self-injectable to improve patient adherence and convenience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Relocation Assistance

Company News

PR Newswire
Nov 10th, 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables

Launches as Top 15 U.S. Generic Drug Manufacturer, Largest U.S. Producer of Active Pharmaceutical Ingredients and Premier U.S. Producer of Sterile Injectables...

Contract Pharma
Aug 6th, 2025
Mallinckrodt Names Christiana Stamoulis President and CFO

Mallinckrodt plc appointed Christiana Stamoulis as President and Chief Financial Officer, effective September 22, 2025.

Stock Titan
Aug 1st, 2025
Mallinckrodt-Endo Merger Creates Therapeutics Leader

Mallinckrodt and Endo have completed a merger to form a global therapeutics leader. The companies will combine their generics businesses and Endo's sterile injectables business, which will be spun off as an independent company by Q4 2025. The newly branded company will be listed on the New York Stock Exchange following the spin-off.

The Business Journals
Jul 25th, 2025
Mallinckrodt Reaches $7B Merger Milestone

Mallinckrodt has reached a milestone in a $7 billion merger deal.

Sharecast
Mar 13th, 2025
Mallinckrodt and Endo to merge in $6.7bn deal

Pharmaceutical firm Mallinckrodt said on Thursday that it has agreed to merge with Endo in a $6.7bn deal.

INACTIVE